Category: atopic dermatitis

A digitally delivered intervention showed significant improvements in treatment adherence and other clinical outcomes in atopic dermatitis (AD) patients, according to a new study.

New research has identified an immune biomarker in newborns that may predict the onset and severity of pediatric atopic dermatitis (AD).

According to a recent study, photoaggravated atopic dermatitis (PAD) severely impacts quality of life for patients. 

According to a recent study, children are more likely to have atopic dermatitis (AD) in the first two years of life if their parents have AD or asthma.

According to a new study, dietary changes may improve symptoms in patients with mild or moderate atopic dermatitis (AD) when used in conjunction with regular treatment. However, the authors note there are risks associated with elimination diets that should be discussed.

According to a new study, taking vitamin D supplements during pregnancy may reduce the likelihood of infants developing atopic dermatitis (AD) in their first year of life.

According to a new study, the prevalence of keratosis pilaris (KP) is low in patients with atopic dermatitis (AD).

According to a new study, depressive symptoms are closely linked to atopic dermatitis (AD) severity and can fluctuate alongside AD severity.

According to a new study, dupilumab shows safety and efficacy for up to four years in treatment of moderate-to-severe atopic dermatitis (AD) in adults.

According to a new study, patients with atopic dermatitis (AD) are more likely to achieve mild disease severity when treated with dupilumab and adjuvant tacrolimus as opposed to dupilumab alone.